Literature DB >> 14053736

MULTIPLE SCLEROSIS: A CURRENT APPRAISAL OF SYMPTOMS AND SIGNS.

R R IVERS, N P GOLDSTEIN.   

Abstract

Entities:  

Keywords:  DIAGNOSIS; MULTIPLE SCLEROSIS; STATISTICS

Mesh:

Year:  1963        PMID: 14053736

Source DB:  PubMed          Journal:  Proc Staff Meet Mayo Clin        ISSN: 0092-699X


× No keyword cloud information.
  9 in total

Review 1.  Physicians, subsequence and consequence.

Authors:  W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

2.  Comparative epidemiological studies of multiple sclerosis in South Africa and Japan.

Authors:  A V Bird; E Satoyoshi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-09       Impact factor: 10.154

Review 3.  The ocular manifestations of multiple sclerosis. 2. Abnormalities of eye movements.

Authors:  D Barnes; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

4.  THE BENIGN FORM OF MULTIPLE SCLEROSIS: RESULTS OF A LONG-TERM STUDY.

Authors:  D MCALPINE
Journal:  Br Med J       Date:  1964-10-24

5.  BLADDER DYSFUNCTION IN MULTIPLE SCLEROSIS.

Authors:  H MILLER; C A SIMPSON; W K YEATES
Journal:  Br Med J       Date:  1965-05-15

6.  Childhood multiple sclerosis with psychotic manifestations.

Authors:  L F Salguero; H H Itabashi; N B Gutierrez
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-12       Impact factor: 10.154

7.  Multiple sclerosis in Kuwait: clinical and epidemiological study.

Authors:  A S Al-Din
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

8.  Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis.

Authors:  C D Betts; M T D'Mellow; C J Fowler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-03       Impact factor: 10.154

9.  Clinical studies of multiple sclerosis in Japan. Multiple sclerosis starting with retrobulbar neuritis.

Authors:  H Shibasaki; Y Kuroda; H Iwashita; Y Kuroiwa
Journal:  J Neurol       Date:  1974       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.